U.S. federal trademark · Serial No. 86392638 · Reg. No. 4723596
Research and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.